Annual Operating Profit
-$18.30 M
+$1.66 M+8.34%
31 December 2023
Summary:
Enveric Biosciences annual operaing income is currently -$18.30 million, with the most recent change of +$1.66 million (+8.34%) on 31 December 2023. During the last 3 years, it has fallen by -$11.88 million (-185.02%). ENVB annual operating profit is now -2222.59% below its all-time high of $862.00 thousand, reached on 31 December 2015.ENVB Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$2.08 M
-$185.30 K-9.76%
30 September 2024
Summary:
Enveric Biosciences quarterly operating income is currently -$2.08 million, with the most recent change of -$185.30 thousand (-9.76%) on 30 September 2024. Over the past year, it has increased by +$1.37 million (+39.59%). ENVB quarterly operating profit is now -265.89% below its all-time high of $1.26 million, reached on 31 December 1998.ENVB Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$10.69 M
+$1.37 M+11.32%
30 September 2024
Summary:
Enveric Biosciences TTM operating income is currently -$10.69 million, with the most recent change of +$1.37 million (+11.32%) on 30 September 2024. Over the past year, it has increased by +$8.18 million (+43.33%). ENVB TTM operating profit is now -1169.10% below its all-time high of $1.00 million, reached on 30 September 1995.ENVB TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ENVB Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.3% | +39.6% | +43.3% |
| 3 y3 years | -185.0% | +40.8% | +41.5% |
| 5 y5 years | -288.1% | -33.1% | -84.1% |
ENVB Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -185.0% | +32.4% | -9.8% | +84.1% | at high | +62.2% |
| 5 y | 5 years | -288.1% | +32.4% | -325.3% | +84.1% | -120.7% | +62.2% |
| alltime | all time | -2222.6% | +32.4% | -265.9% | +90.4% | -1169.1% | +62.2% |
Enveric Biosciences Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$2.08 M(+9.8%) | -$10.69 M(-11.3%) |
| June 2024 | - | -$1.90 M(-23.4%) | -$12.06 M(-24.2%) |
| Mar 2024 | - | -$2.48 M(-41.5%) | -$15.91 M(-13.0%) |
| Dec 2023 | -$18.30 M(-8.3%) | -$4.23 M(+22.7%) | -$18.30 M(-3.0%) |
| Sept 2023 | - | -$3.45 M(-40.1%) | -$18.87 M(-10.5%) |
| June 2023 | - | -$5.75 M(+18.4%) | -$21.07 M(+5.2%) |
| Mar 2023 | - | -$4.86 M(+1.2%) | -$20.03 M(+0.3%) |
| Dec 2022 | -$19.96 M(-26.3%) | -$4.80 M(-15.1%) | -$19.96 M(-29.4%) |
| Sept 2022 | - | -$5.66 M(+20.2%) | -$28.29 M(+8.2%) |
| June 2022 | - | -$4.71 M(-1.9%) | -$26.15 M(+5.4%) |
| Mar 2022 | - | -$4.80 M(-63.5%) | -$24.80 M(-8.4%) |
| Dec 2021 | -$27.07 M(+321.7%) | -$13.13 M(+273.2%) | -$27.07 M(+48.2%) |
| Sept 2021 | - | -$3.52 M(+4.6%) | -$18.27 M(+19.9%) |
| June 2021 | - | -$3.36 M(-52.4%) | -$15.24 M(+20.5%) |
| Mar 2021 | - | -$7.06 M(+63.3%) | -$12.65 M(+76.0%) |
| Dec 2020 | -$6.42 M(+1.5%) | -$4.33 M(+783.1%) | -$7.19 M(+48.3%) |
| Sept 2020 | - | -$489.80 K(-36.2%) | -$4.84 M(-18.2%) |
| June 2020 | - | -$767.50 K(-52.1%) | -$5.92 M(-10.7%) |
| Mar 2020 | - | -$1.60 M(-19.3%) | -$6.63 M(+4.8%) |
| Dec 2019 | -$6.32 M(+34.1%) | -$1.99 M(+26.8%) | -$6.32 M(+8.9%) |
| Sept 2019 | - | -$1.56 M(+6.0%) | -$5.81 M(+11.9%) |
| June 2019 | - | -$1.48 M(+13.7%) | -$5.19 M(+11.4%) |
| Mar 2019 | - | -$1.30 M(-11.5%) | -$4.66 M(-1.2%) |
| Dec 2018 | -$4.71 M(-59.0%) | -$1.47 M(+54.9%) | -$4.71 M(-33.1%) |
| Sept 2018 | - | -$946.60 K(+0.2%) | -$7.04 M(-29.8%) |
| June 2018 | - | -$944.90 K(-30.4%) | -$10.04 M(-19.2%) |
| Mar 2018 | - | -$1.36 M(-64.3%) | -$12.43 M(+8.1%) |
| Dec 2017 | -$11.49 M(+202.8%) | -$3.80 M(-3.7%) | -$11.49 M(+15.9%) |
| Sept 2017 | - | -$3.94 M(+18.2%) | -$9.91 M(+58.7%) |
| June 2017 | - | -$3.33 M(+691.3%) | -$6.25 M(+73.0%) |
| Mar 2017 | - | -$421.20 K(-81.0%) | -$3.61 M(-4.9%) |
| Dec 2016 | -$3.79 M(-540.2%) | -$2.22 M(+702.6%) | -$3.79 M(+140.4%) |
| Sept 2016 | - | -$276.10 K(-60.4%) | -$1.58 M(+15.3%) |
| June 2016 | - | -$696.80 K(+15.0%) | -$1.37 M(+628.9%) |
| Mar 2016 | - | -$605.90 K(+805.7%) | -$187.90 K(-146.4%) |
| Dec 2015 | $862.00 K(-2728.0%) | - | - |
| Sept 2015 | - | -$66.90 K(-113.8%) | $405.30 K(-13.6%) |
| June 2015 | - | $484.90 K(<-9900.0%) | $469.10 K(-1805.8%) |
| Mar 2015 | - | -$2300.00(-77.9%) | -$27.50 K(-16.2%) |
| Dec 2014 | -$32.80 K(+20.6%) | -$10.40 K(+235.5%) | -$32.80 K(-10.1%) |
| Sept 2014 | - | -$3100.00(-73.5%) | -$36.50 K(-3.9%) |
| June 2014 | - | -$11.70 K(+53.9%) | -$38.00 K(+25.8%) |
| Mar 2014 | - | -$7600.00(-46.1%) | -$30.20 K(+10.6%) |
| Dec 2013 | -$27.20 K(+19.8%) | -$14.10 K(+206.5%) | -$27.30 K(+17.7%) |
| Sept 2013 | - | -$4600.00(+17.9%) | -$23.20 K(0.0%) |
| June 2013 | - | -$3900.00(-17.0%) | -$23.20 K(-0.9%) |
| Mar 2013 | - | -$4700.00(-53.0%) | -$23.40 K(+3.1%) |
| Dec 2012 | -$22.70 K(-27.7%) | -$10.00 K(+117.4%) | -$22.70 K(-11.7%) |
| Sept 2012 | - | -$4600.00(+12.2%) | -$25.70 K(+3.6%) |
| June 2012 | - | -$4100.00(+2.5%) | -$24.80 K(+2.1%) |
| Mar 2012 | - | -$4000.00(-69.2%) | -$24.30 K(-22.6%) |
| Dec 2011 | -$31.40 K(-12.5%) | -$13.00 K(+251.4%) | -$31.40 K(+5.4%) |
| Sept 2011 | - | -$3700.00(+2.8%) | -$29.80 K(-6.0%) |
| June 2011 | - | -$3600.00(-67.6%) | -$31.70 K(-2.8%) |
| Mar 2011 | - | -$11.10 K(-2.6%) | -$32.60 K(-9.2%) |
| Dec 2010 | -$35.90 K(-35.4%) | -$11.40 K(+103.6%) | -$35.90 K(-20.8%) |
| Sept 2010 | - | -$5600.00(+24.4%) | -$45.30 K(+2.5%) |
| June 2010 | - | -$4500.00(-68.8%) | -$44.20 K(-17.1%) |
| Mar 2010 | - | -$14.40 K(-30.8%) | -$53.30 K(-4.1%) |
| Dec 2009 | -$55.60 K | -$20.80 K(+362.2%) | -$55.60 K(-20.3%) |
| Sept 2009 | - | -$4500.00(-66.9%) | -$69.80 K(-4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2009 | - | -$13.60 K(-18.6%) | -$73.00 K(-25.1%) |
| Mar 2009 | - | -$16.70 K(-52.3%) | -$97.40 K(-35.7%) |
| Dec 2008 | -$151.40 K(-28.0%) | -$35.00 K(+354.5%) | -$151.40 K(-76.5%) |
| Sept 2008 | - | -$7700.00(-79.7%) | -$645.00 K(-7.4%) |
| June 2008 | - | -$38.00 K(-46.3%) | -$696.50 K(+36.1%) |
| Mar 2008 | - | -$70.70 K(-86.6%) | -$511.60 K(+143.7%) |
| Dec 2007 | -$210.40 K(-40.5%) | -$528.60 K(+792.9%) | -$209.90 K(-180.5%) |
| Sept 2007 | - | -$59.20 K(-140.3%) | $260.60 K(+0.8%) |
| June 2007 | - | $146.90 K(-36.4%) | $258.60 K(+400.2%) |
| Mar 2007 | - | $231.00 K(-497.6%) | $51.70 K(-114.6%) |
| Dec 2006 | -$353.50 K(+291.5%) | -$58.10 K(-5.1%) | -$353.50 K(-27.1%) |
| Sept 2006 | - | -$61.20 K(+2.0%) | -$485.00 K(+24.5%) |
| June 2006 | - | -$60.00 K(-65.6%) | -$389.60 K(+42.8%) |
| Mar 2006 | - | -$174.20 K(-8.1%) | -$272.90 K(+201.9%) |
| Dec 2005 | -$90.30 K(-40.5%) | -$189.60 K(-654.4%) | -$90.40 K(-133.7%) |
| Sept 2005 | - | $34.20 K(-39.7%) | $268.60 K(+75.6%) |
| June 2005 | - | $56.70 K(+583.1%) | $153.00 K(-818.3%) |
| Mar 2005 | - | $8300.00(-95.1%) | -$21.30 K(-86.0%) |
| Dec 2004 | -$151.80 K(-68.6%) | $169.40 K(-308.1%) | -$151.70 K(-64.0%) |
| Sept 2004 | - | -$81.40 K(-30.8%) | -$421.60 K(-4.8%) |
| June 2004 | - | -$117.60 K(-3.7%) | -$442.90 K(-17.2%) |
| Mar 2004 | - | -$122.10 K(+21.5%) | -$534.70 K(+10.5%) |
| Dec 2003 | -$483.80 K(-3507.0%) | -$100.50 K(-2.1%) | -$483.70 K(+19.1%) |
| Sept 2003 | - | -$102.70 K(-51.0%) | -$406.10 K(+38.9%) |
| June 2003 | - | -$209.40 K(+194.5%) | -$292.30 K(+264.9%) |
| Mar 2003 | - | -$71.10 K(+210.5%) | -$80.10 K(-672.1%) |
| Dec 2002 | $14.20 K(-104.5%) | -$22.90 K(-306.3%) | $14.00 K(+197.9%) |
| Sept 2002 | - | $11.10 K(+296.4%) | $4700.00(-102.5%) |
| June 2002 | - | $2800.00(-87.8%) | -$185.40 K(-35.9%) |
| Mar 2002 | - | $23.00 K(-171.4%) | -$289.40 K(-8.3%) |
| Dec 2001 | -$315.80 K(-188.2%) | -$32.20 K(-82.0%) | -$315.70 K(-4.8%) |
| Sept 2001 | - | -$179.00 K(+76.9%) | -$331.50 K(+556.4%) |
| June 2001 | - | -$101.20 K(+2966.7%) | -$50.50 K(-130.3%) |
| Mar 2001 | - | -$3300.00(-93.1%) | $166.60 K(-53.5%) |
| Dec 2000 | $358.10 K(-21.4%) | -$48.00 K(-147.1%) | $358.20 K(-11.8%) |
| Sept 2000 | - | $102.00 K(-12.0%) | $406.20 K(+33.5%) |
| June 2000 | - | $115.90 K(-38.4%) | $304.20 K(+61.6%) |
| Mar 2000 | - | $188.30 K(-85.0%) | $188.30 K(-108.4%) |
| Dec 1999 | $455.60 K(-123.4%) | - | - |
| Dec 1998 | -$1.94 M(-58.5%) | $1.26 M(-196.6%) | -$2.24 M(-57.5%) |
| Sept 1998 | - | -$1.30 M(+18.2%) | -$5.29 M(+8.2%) |
| June 1998 | - | -$1.10 M(0.0%) | -$4.89 M(0.0%) |
| Mar 1998 | - | -$1.10 M(-38.4%) | -$4.89 M(0.0%) |
| Dec 1997 | -$4.69 M(-81.4%) | -$1.79 M(+98.5%) | -$4.89 M(-80.3%) |
| Sept 1997 | - | -$900.00 K(-18.2%) | -$24.80 M(-0.8%) |
| June 1997 | - | -$1.10 M(0.0%) | -$25.00 M(-2.0%) |
| Mar 1997 | - | -$1.10 M(-94.9%) | -$25.50 M(+1.2%) |
| Dec 1996 | -$25.20 M(+641.3%) | -$21.70 M(+1873.1%) | -$25.20 M(+227.3%) |
| Sept 1996 | - | -$1.10 M(-31.3%) | -$7.70 M(+22.2%) |
| June 1996 | - | -$1.60 M(+100.0%) | -$6.30 M(+43.2%) |
| Mar 1996 | - | -$800.00 K(-81.0%) | -$4.40 M(+33.3%) |
| Dec 1995 | -$3.40 M(+209.1%) | -$4.20 M(-1500.0%) | -$3.30 M(-430.0%) |
| Sept 1995 | - | $300.00 K(0.0%) | $1.00 M(-176.9%) |
| June 1995 | - | $300.00 K(0.0%) | -$1.30 M(-13.3%) |
| Mar 1995 | - | $300.00 K(+200.0%) | -$1.50 M(-11.8%) |
| Dec 1994 | -$1.10 M(-42.1%) | - | - |
| Nov 1994 | - | $100.00 K(-105.0%) | -$1.70 M(0.0%) |
| Aug 1994 | - | -$2.00 M(-2100.0%) | -$1.70 M(-666.7%) |
| Aug 1994 | -$1.90 M | - | - |
| May 1994 | - | $100.00 K(0.0%) | $300.00 K(+50.0%) |
| Feb 1994 | - | $100.00 K(0.0%) | $200.00 K(+100.0%) |
| Nov 1993 | - | $100.00 K | $100.00 K |
FAQ
- What is Enveric Biosciences annual operaing income?
- What is the all time high annual operating profit for Enveric Biosciences?
- What is Enveric Biosciences annual operating profit year-on-year change?
- What is Enveric Biosciences quarterly operating income?
- What is the all time high quarterly operating profit for Enveric Biosciences?
- What is Enveric Biosciences quarterly operating profit year-on-year change?
- What is Enveric Biosciences TTM operating income?
- What is the all time high TTM operating profit for Enveric Biosciences?
- What is Enveric Biosciences TTM operating profit year-on-year change?
What is Enveric Biosciences annual operaing income?
The current annual operating profit of ENVB is -$18.30 M
What is the all time high annual operating profit for Enveric Biosciences?
Enveric Biosciences all-time high annual operaing income is $862.00 K
What is Enveric Biosciences annual operating profit year-on-year change?
Over the past year, ENVB annual operaing income has changed by +$1.66 M (+8.34%)
What is Enveric Biosciences quarterly operating income?
The current quarterly operating profit of ENVB is -$2.08 M
What is the all time high quarterly operating profit for Enveric Biosciences?
Enveric Biosciences all-time high quarterly operating income is $1.26 M
What is Enveric Biosciences quarterly operating profit year-on-year change?
Over the past year, ENVB quarterly operating income has changed by +$1.37 M (+39.59%)
What is Enveric Biosciences TTM operating income?
The current TTM operating profit of ENVB is -$10.69 M
What is the all time high TTM operating profit for Enveric Biosciences?
Enveric Biosciences all-time high TTM operating income is $1.00 M
What is Enveric Biosciences TTM operating profit year-on-year change?
Over the past year, ENVB TTM operating income has changed by +$8.18 M (+43.33%)